top

  Info

  • Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.

  Info

  • Utilizzare questo link per rimuovere la selezione effettuata.
Antiviral Agents
Antiviral Agents
Autore Adamson Catherine
Pubbl/distr/stampa Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020
Descrizione fisica 1 online resource (386 p.)
Soggetto topico Biology, life sciences
Research and information: general
Soggetto non controllato acteoside
acute/latent infection
acyclovir
adoptive cell therapy
antipsychotic drug
antiviral
antiviral activity
antiviral agent
antiviral agents
antiviral drug
antiviral effect
antiviral inhibitor
antiviral strategies
branched peptides
brevilin A
Burkitt lymphoma cells
C-FRA
cathelicidins
central nervous system
chemical footprinting
Clerodendrum trichotomum
clozapine
combination antiretroviral therapy (cART)
congenital infection
coxsackievirus B4
CRISPR/Cas
cytomegalovirus
defensins
dried blood spots
dried plasma spots
drug discovery
endocytosis
enteroviruses
epigallocatechin gallate
Epstein-Barr virus
Ethiopia
flavivirus
flavonoids
fluoxetine
furin inhibitor
ganciclovir
genistein
ginsenoside Rg1
glycosphingolipids
HCMV vaccine
hemagglutinin (HA)
heparan sulfate
hepatitis C virus
hepcidins
herpes B virus
herpes viruses
herpesvirus
HIV
human antimicrobial peptides
human immunodeficiency virus
ie-1 gene
IE1
IE2
immediate-early
influenza A virus
influenza A virus (IAV)
Japanese encephalitis virus
latent infection
lectin
lipid biosynthesis
LUMS1
lytic gene expression
macacine herpesvirus-1
measles virus
microvirin
mutations
n/a
neural stem cells
NF-κB signaling pathway
non-immunogenic
NS5
nucleic acid-based therapeutic approach
nucleoside analogues
oleanane-type derivatives
orthohantavirus
pediatrics
PEI
persistent infection
phenyl-benzotriazoles
Plantago asiatica
polyethylenimine
Porcine circovirus type 2
porcine reproductive and respiratory syndrome virus
pre-treatment drug resistance
precursor membrane protein
pro-inflammatory factor
prodrugs
protein drugs
ProTides
PRRSV
quantitative real-time PCR
replication
resistance
Rev response element
ribozyme
RNA interference
RNA-dependent RNA polymerase
RSV
sesquiterpene lactone
SHAPE
small molecule
sphingolipids
Surveyor nuclease mutation detection assay
TALEN
therapeutic effects
therapeutic strategies
transferrins
treatments
tropism
viral entry
virion internalization
virus attachment
virus entry inhibitors
viruses
Zika virus
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910557448703321
Adamson Catherine  
Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Fibroblast Growth Factor Receptor (FGFR) Signaling Pathway in Tumor
Fibroblast Growth Factor Receptor (FGFR) Signaling Pathway in Tumor
Autore Holzmann Klaus
Pubbl/distr/stampa Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020
Descrizione fisica 1 online resource (276 p.)
Soggetto topico Medicine
Soggetto non controllato adenocarcinoma of the esophagogastric junction
AKT
anticancer
astrocytoma
autocrine signaling
autophagy
brain cancer
breast cancer
cancer
cancer signaling
cancer-associated fibroblasts
coreceptor
ERK
ERK1/2
estrogen
FGF
FGF-mediated signaling
FGF18
FGF19
FGF2
FGF8
FGFR
FGFR1
FGFR2
FGFR2c
FGFR4
fibroblast growth factor
fibroblast growth factor receptors
FRS2
gastric cancer
gene regulation
GPER
HCC
HEK293
immunohistochemistry
infigratinib sensitivity
inhibitors
JNK1
keratinocyte
kinase inhibitor
LY2874455
malignant glioma
malignant pleural mesothelioma
melanoma
membrane proteins
monoclonal antibody
MTOR
n/a
negative feedback loop
neoadjuvant therapy
neurite outgrowth
NVP-BGJ398
optogenetics
overall survival
PC12
phosphorylation
prognosis
receptor cross-talk
receptor kinase
resistance
review
sarcoma
seborrheic keratosis
serine
signaling
skin
small molecule
Sprouty proteins
squamous and basal cell carcinoma
structure
targeted therapy
tumor promoter
tumor suppressor
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Altri titoli varianti Fibroblast Growth Factor Receptor
Record Nr. UNINA-9910557898903321
Holzmann Klaus  
Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Oncolytic Virus Immunotherapy
Oncolytic Virus Immunotherapy
Autore Marchini Antonio
Pubbl/distr/stampa Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022
Descrizione fisica 1 online resource (366 p.)
Soggetto topico Clinical and internal medicine
Medicine and Nursing
Soggetto non controllato adenovirus
adoptive T cell therapy
antigen-agnostic vaccination
antitumor immune response
arming
biomarkers
cancer
cancer immune therapy
cancer immunotherapy
cancer therapy
CAR T cell
checkpoint inhibitor
checkpoint inhibitors
class I HLA
clinical trials
colorectal cancer
combination therapy
combinatory therapy
CTLA-4
delivery
DNA methyltransferase inhibitor (DNMTi)
epigenetic silencing
genetic modification
glioblastoma
HER2
herpes simplex virus
HSV-1
immune checkpoint blockade
immune checkpoint inhibitor
immunoediting
immunogenic cell death
immunostimulatory
immunosurveillance
immunotherapy
measles virus
melanoma
multi-stage
n/a
NDV
newcastle disease virus
oncogenic signaling
oncolytic
oncolytic adenovirus
oncolytic virus
oncolytic viruses
pancreatic cancer
pancreatic ductal adenocarcinoma
parvovirus
PD-1
PD-L1
personalized oncolyticvirotherapy
RAS
reovirus
retargeted virus
small molecule
targeting
tropism retargeting
tumor
tumor microenvironment
type I interferon
vaccination
vector engineering
vesicular stomatitis virus
viral mimicry
virotherapy
αvβ6 integrin
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910566462203321
Marchini Antonio  
Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui